News & Events
- Lt. Governor Dewhurst Announces Appointments to Medicaid Reform Waiver Legislative Oversight Committee
Lt. Governor David Dewhurst appointed four members of the Texas Senate to the Medicaid Reform Waiver Legislative Oversight Committee. "As a state, Texas pays 40 percent of the cost for Medicaid, but the federal government makes 100 percent of the decisions," said Lt. Governor Dewhurst. "The Medicaid Reform Waiver Legislative Oversight Committee will help design a new model for Medicaid, removing federal regulatory barriers and giving Texas the flexibility we need to provide better health care without busting the state budget." The Medicaid Reform Waiver Legislative Oversight Committee facilitates the design and development of the Medicaid reform waiver and facilitates a smooth transition from existing Medicaid payment systems and benefits to a more efficient and cost-effective model. Lt. Governor Dewhurst appointed the following members to the committee: Senator Jane Nelson (R-Flower Mound), Senator Bob Deuell (R-Greenville), Senator Dan Patrick (R-Houston) and Senator Royce West (D-Dallas).
- Texas Pharmacy Groups Warn Of Devastating Impact Of Medicaid Cuts To Patients & Small Businesses
Texas pharmacy groups today warned that Texas’ planned move to managed care for pharmacy services on March 1st of 2012 will have a devastating impact on the state’s community pharmacies and on the poor they serve. This warning comes as the Texas House of Representatives committee on Public Health is scheduled to meet today to discuss managed care. -- More Information
- Rxperts Spring Leadership Symposium, March 23-24, 2012
Join pharmacy professionals for a critical meeting focused on the state of the profession, your role in patient care and protecting the pharmacy profession. You’ll have direct contact with leaders and elected officials including Attorney General Abbott, Texas Comptroller Combs, Health and Human Services Commissioner Suehs, and experts in the field of politics and grassroots involvement. -- More Information
- Johnson & Johnson to pay $158 million to Texas to Resolve Risperdal Marketing Claims
Johnson & Johnson's Janssen Pharmaceuticals unit announced Thursday that it reached a settlement agreement with Texas officials under which it will pay $158 million to resolve claims that it illegally marketed Risperdal (risperidone). -- Read Article
- Houston Area Prescription Fraud Alert
An African-American obese female has been calling in forged prescriptions in the Houston area. Forged prescriptions for Xanax, Norco and Soma. Suspect has also faxed the forged prescriptions after calling them in. Contact LaToya Abernathy at (713) 777-7160 for further information.
- News Archive Page
|
From Your Leaders
President
Dorinda Martin
President's Message
Chief Executive Officer
Joe DaSilva
CEO Blog
Quick Links

January
Quality Assurance and
Continuous Quality Improvement
TPA Affiliates
|
|
|